Biotech Values

[Titan V]

#Biotech M&A deals during last bubble didn't work out too well...

$MRK -> Cubist $9.5B
$ALXN -> Synageva $8.4B
$CELG -> Receptos $7.2B
$ABBV -> Stemcentrx $5.8B
$MRK -> Idenix $3.8B
$AZN -> ZS Pharma $2.7B

#Biotech M&A deals during last bubble didn't work out too well...$MRK -> Cubist $9.5B$ALXN -> Synageva $8.4B$CELG -> Receptos $7.2B$ABBV -> Stemcentrx $5.8B$MRK -> Idenix $3.8B$AZN -> ZS Pharma $2.7B

— Andy Biotech (@AndyBiotech) March 22, 2018